Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy

Neuropharmacology

Volumn 50, Issue 8, 2006, Pages 1059-1071

  Citraro, Rita ^a   Russo, Emilio ^a   Di Paola, Eugenio Donato ^a   Ibbadu, Guido Ferreri ^a   Gratteri, Santo ^b   Marra, Rosario ^b   De Sarro, Giovambattista ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b CNR   (Italy)

Author keywords

Absence seizures; Allopregnanolone; Ganaxolone; Neurosteroids; Pregnenolone sulphate; Primary somatosensory cortex; Thalamus; WAG Rij rat

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; GANAXOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROSTEROID; PREGNENOLONE SULFATE;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CANNULA; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ELECTROCORTICOGRAPHY; ELECTRODE; FRONTAL CORTEX; GENERALIZED EPILEPSY; GENETIC MODEL; INJECTION; MALE; MICROINJECTION; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; RAT; SOMATOSENSORY CORTEX; SPIKE WAVE; THALAMOCORTICAL TRACT; THALAMUS NUCLEUS; THALAMUS VENTRAL NUCLEUS;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; MALE; MICROINJECTIONS; PREGNANOLONE; PREGNENOLONE; RATS; RATS, INBRED STRAINS; TIME FACTORS;

EID: 33744549505     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.02.011     Document Type: Article

References (116)

1. Avoli M. Epilepsy. In: Martin D.L., and Olsen R.W. (Eds). GABA in the Nervous System: The View at Fifty Years (2000), Lippincot Williams & Wilkins, Philadelphia 293-316
2. Bal T., Debay D., and Destexhe A. Cortical feedback controls the frequency and synchrony of oscillations in the visual thalamus. Journal of Neuroscience 20 (2000) 7478-7488
3. Banerjee P.K., and Snead III O.C. Involvement of excitatory amino acid mechanisms in gamma-hydroxybutyrate model of generalized absence seizures in rats. Neuropharmacology 31 (1992) 1009-1019
4. Banerjee P.K., and Snead III O.C. Thalamic NMDA receptors in the gamma-hydroxybutyrate model of absence seizures: a cerebral microinjection study in rats. Neuropharmacology 34 (1995) 43-53
5. Baulieu E.E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Progress in Hormone Research 52 (1997) 1-33
6. Baulieu E.E. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23 (1998) 963-987
7. Baulieu E.E., and Robel P. Neurosteroids: a new brain function?. Journal of Steroid Biochemistry and Molecular Biology 37 (1990) 395-403
8. Bazian A.S., Midzianovskaia I.S., Kuznetsova G.D., Sarkisova K.Iu., Getsova V.M., Orlova N.V., and Lushkin A.A. Possible mechanisms for forming typological features of behavior of WAG/Rij line rats. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni I P Pavlova 51 (2001) 709-716
9. Belelli D., Bolger M.B., and Gee K.W. Anticonvulsant profile of the progesterone metabolite 5alpha-pregnan-3alpha-ol-20-one. European Journal Pharmacology 166 (1989) 325-329
10. Belelli D., Lan N.C., and Gee K.W. Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex. Neuroscience and Biobehavioral Review 14 (1990) 315-322
11. Bergeron R., de Montigny C., and Debonnel G. Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. Journal of Neuroscience 16 (1996) 1193-1202
12. A receptor. Brain Research 33 (1991) 23-29
13. Blumenfeld H., and McCormick D.A. Corticothalamic inputs control the pattern of activity generated in thalamocortical networks. Journal of Neuroscience 20 (2000) 5153-5162
14. Bradford H.F. Glutamate, GABA and epilepsy. Progress in Neurobiology 47 (1995) 477-511
15. Budziszewska B., Siwanowicz J., Leskiewicz M., Jaworska-Feil L., and Lason W. Protective effects of neurosteroids against NMDA-induced seizures and lethality in mice. European Neuropsychopharmacology 8 (1998) 7-12
16. Budziszewska B., Van Luijtelaar G., Coenen A.M., Leskiewicz M., and Lason W. Effects of neurosteroids on spike-wave discharges in the genetic epileptic WAG/Rij rat. Epilepsy Research 33 (1999) 23-29
17. Bullock A.E., Clark A.L., Grady S.R., Robinson S.F., Slobe B.S., Marks M.J., and Collins A.C. Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes. Journal of Neurochemistry 68 (1997) 2412-2423
18. Carter R.B., Wood P.L., Wieland S., Hawkinson J.E., Belelli D., Lambert J.J., White H.S., Wolf H.H., Mirsadeghi S., Tahir S.H., Bolger M.B., Lan N.C., and Gee K.W.J. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor. Journal of Pharmacology and Experimental. Therapeutics 280 (1997) 1284-1295
19. Coenen A.M., Blezer E., and Van Luijtelaar E.L. Effects of the GABA-uptake inhibitor tiagabine on electroencephalogram, spike-wave discharges and behaviour of rats. Epilepsy Research 21 (1995) 89-94
20. Coenen A.M., Drinkenburg W.H.I.M., Inoue M., and van Luijtelaar E.L.J.M. Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats. Epilepsy Research 12 (1992) 75-86
21. Coenen A.M., and van Luijtelaar E.L. Effects of diazepam and two beta-carbolines on epileptic activity and on EEG and behavior in rats with absence seizures. Pharmacology Biochemistry and Behaviour 32 (1989) 27-35
22. Coenen A.M., and Van Luijtelaar E.L. Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of rats. Behavior Genetics 33 (2003) 635-655
23. Compagnone N.A., and Mellon S.H. Neurosteroids: biosynthesis and function of these novel neuromodulators. Frontiers in Neuroendocrinology 21 (2000) 1-56
24. 35S]-TBPS binding in the brain of rats exposed to isoniazid, pentylenetetrazol or stress. British Journal of Pharmacology 118 (1996) 839-846
25. B receptors in excitation and inhibition of thalamocortical cells. Trends in Neuroscience 14 (1991) 16-21
26. Czlonkowska A.I., Krzascik P., Sienkiewcz-Jarosz H., Siemiatkowski M., Szyndler J., Bidzinski A., and Plaznik A. The effects of neurosteroids on picrotoxin-, bicuculline- and NMDA-induced seizures, and a hypnotic effect of ethanol. Pharmacology. Biochemistry and Behavior 67 (2000) 345-353
27. Czlonkowska A.I., Krzascik P., Sienkiewicz-Jarosz H., Siemiatkowski M., Szyndler J., Maciejak P., Bidzinski A., and Plaznik A. Tolerance to the anticonvulsant activity of midazolam and allopregnanolone in a model of picrotoxin seizures. European Journal of Pharmacology 10 (2001) 121-127
28. Czuczwar S.J., and Patsalos P.N. The new generation of GABA enhancers. Potential in the treatment of epilepsy. CNS Drugs 15 (2001) 339-350
29. D'Arcangelo G., D'Antuono M., Biagini G., Warren R., Tancredi V., and Avoli M. Thalamocortical oscillations in a genetic model of absence seizures. European Journal of Neuroscience 16 (2002) 2383-2393
30. Danober L., Deransart C., Depaulis A., Vergnes M., and Marescaux C. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Progress in Neurobiology 55 (1998) 27-57
31. De Sarro G.B., Meldrum B.S., De Sarro A., and Patel S. Excitatory neurotransmitters in the lateral habenula and peduncolopontine nucleus of rat modulate limbic seizures induced by pilocarpine. Brain Research 591 (1992) 209-222
32. B receptors on epileptic electrocortical discharges induced by pilocarpine or NMDA. Pharmacological Communications 8 (1996) 111-116
33. Follesa P., Mostallino M.C., Biggio F., Gorini G., Caria S., Busonero F., Murru L., Mura M.L., Sanna E., and Biggio G. Distinct patterns of expression and regulation of GABA receptors containing the delta subunit in cerebellar granule and hippocampal neurons. Journal of Neurochemistry 94 (2005) 659-671
34. Gareri P., Condorelli D., Belluardo N., Citrato R., Barresi V., Trovato-Salinato A., Mudò G., Ferreri Iddadu G., Russo E., and De Sarro G. Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice). Neuropharmacology 49 (2005) 551-563
35. Gasior M., Carter R.B., Goldberg S.R., and Witkin J.M. Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam. Journal of Pharmacological and Experimental Therapeutics 282 (1997) 543-553
36. Gasior M., Carter R.B., and Witkin J.M. Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends in Pharmacological Science 20 (1999) 107-112
37. Gasior M., Ungard J.T., Beekman M., Carter R.B., and Witkin J.M. Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: comparison with diazepam and valproate. Neuropharmacology 27 (2000) 1184-1196
38. Gee K.W. Steroid modulation of the GABA/benzodiazepine receptor-linked chloride ionophore. Molecular Neurobiology 2 (1988) 291-317
39. Gee K.W., Bolger M.B., Brinton R.E., Coirini H., and McEwen B.S. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. Journal of Pharmacology and Experimental Therapeutics 246 (1988) 803-812
40. A receptor complex: the pharmacological properties and therapeutic potential of epalons. Critical Reviews in Neurobiology 9 (1995) 207-227
41. Gloor P., and Fariello R.G. Generalized epilepsy: some of its cellular mechanisms differ from those of focal epilepsy. Trends in Neuroscience 11 (1988) 63-68
42. 3H]muscimol binding to the GABAA receptor complex in rat cortex. European Journal of Pharmacology 288 (1995) 157-162
43. A receptors complex. Journal of Pharmacology and Experimental Therapeutics 241 (1987) 346-353
44. 3H]flunitrazepam binding and gamma-aminobutyric acidA receptor function. Molecular Pharmacology 46 (1994) 977-985
45. Herzog A.G. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 10 (1999) 1917-1918
46. Herzog A.G., Klein P., and Ransil B.J. Three patterns of catamenial epilepsy. Epilepsia 38 (1997) 1082-1088
47. Horishita T., Minami K., Uezono Y., Shiraishi M., Ogata J., Okamoto T., Terada T., and Sata T. The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptor-induced responses in Xenopus oocytes expressing M1 and M3 receptors. Naunyn Schmiedeberg's Archives of Pharmacology 371 (2005) 221-228
48. Hosford D.A., Wang Y., and Cao Z. Differential effects mediated by GABAA receptors in thalamic nuclei in lh/lh model of absence seizures. Epilepsy Research 27 (1997) 55-65
49. B mediated inhibition in thalamic relay neurons through effects in nucleus reticularis. Journal of Physiology 71 (1994) 2576-2581
50. Huntsman M.M., Porcello D.M., Homanics G.E., DeLorey T.M., and Huguenard J.R. Reciprocal inhibitory connections and network synchrony in the mammalian thalamus. Science 283 (1999) 541-543
51. ++ responses: structure-activity studies. Journal of Pharmacology and Experimental Therapeutics 271 (1994) 677-682
52. Kim U., Sanchez-Vives M.V., and McCormick D.A. Functional dynamics of GABAergic inhibition in the thalamus. Science 278 (1997) 130-134
53. Knight A.R., and Bowery N.G. GABA receptors in rats with spontaneous generalized nonconvulsive epilepsy. Journal of Neural Transmission 35 Suppl. (1992) 189-196
54. Koerner C., Danober L., Boehrer A., Marescaux C., and Vergnes M. Thalamic NMDA transmission in a genetic model of absence epilepsy in rats. Epilepsy Research 25 (1996) 11-19
55. Kokate T.G., Banks M.K., Magee T., Yamaguchi S., and Rogawski M.A. Finasteride, a 5alpha-reductase inhibitor, blocs the anticonvulsant activity of progesterone in mice. Journal of Pharmacology and Experimental Therapeutics 288 (1999) 679-684
56. Kokate T.G., Svensson B.E., and Rogawski M.A. Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation. Journal of Pharmacology and Experimental Therapeutics 270 (1994) 1223-1229
57. Lambert J.J., Belelli D., Hill-Venning C., and Peters J.A. Neurosteroids and GABA receptor function. Trends in Pharmacological Science 16 (1995) 295-303
58. A receptors. Progress in Neurobiology 71 (2003) 67-80
59. Landgren S., Aasly J., Backstrom T., Dubrovsky B., and Danielsson E. The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex. Acta Physiologica Scandinavia 131 (1987) 33-42
60. Landisman C.E., Long M.A., Beierlein M., Deans M.R., Paul D.L., and Connors B.W. Electrical synapses in the thalamic reticular nucleus. Journal of Neuroscience 22 (2002) 1002-1009
61. Loscher W., and Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices. Epilepsy Research 9 (1991) 1-10
62. Loscher W., and Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Research 2 (1988) 145-181
63. Loscher W., and Schmidt D. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?. Epilepsy Research 17 (1994) 95-134
64. Macdonald R.L., and Olsen R.W. GABAA receptor channels. Annual Review of Neuroscience 17 (1994) 569-602
65. A receptor. Neurosteroids and Brain Function. Fidia Research Foundation Symposium Series vol. 8 (1991), Thieme Medical Publishers, New York 109-117
66. A receptor. Mechanism of action and physiological significance. Progress in Neurobiology 38 (1992) 379-395
67. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 23 (1986) 1004-1007
68. Majewska M.D., and Schwartz R.D. Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain?. Brain Research 24 (1987) 355-360
69. Maksay G.B., Laube H., and Betz H. Subunit-specific modulation of glycine receptors by neurosteroids. Neuropharmacology 41 (2001) 369-376
70. Malayev A., Gibbs T.T., and Farb D.H. Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. British Journal of Pharmacology 135 (2002) 901-909
71. Manning J.-P.A., Richards D.A., Leresche N., Crunelli V., and Bowery N.G. Cortical area specific block of genetically determined absence seizures by ethosuximide. Neuroscience 123 (2004) 5-9
72. Marescaux C., Vergnes M., and Depaulis A. Genetic absence epilepsy in rats from Strasbourg. Journal of Neural Transmission 35 (1992) 37-69
73. Meeren H.K., Pijn J.P., Van Luijtelaar E.L., Coenen A.M., and Lopes da Silva F.H. Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. Journal of Neuroscience 22 (2002) 1480-1495
74. Mellon S.H. Neurosteroids: biochemistry, modes of action, and clinical relevance. Journal of Clinical Endocrinological Metabolism 78 (1994) 1003-1008
75. Mennerick S., He Y., Jiang X., Manion B.D., Wang M., Shute A., Benz A., Evers A.S., Covey D.F., and Zorumski C.F. Selective antagonism of 5alpha-reduced neurosteroid effects at GABA(A) receptors. Molecular Pharmacology 65 (2004) 1191-1197
76. Mensah-Nyagan A., Do-Rego J.L., Beaujean D., Luu-The V., Pelletier G., and Vaudry H. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacological Reviews 51 (1999) 63-81
77. Monaghan E.P., McAuley J.W., and Data J.L. Ganaxolone: a novel positive allosteric modulator of the GABA(A) receptor complex for the treatment of epilepsy. Expert Opinion on Investigational Drugs 8 (1999) 1663-1671
78. 3H]norepinephrine release evoked by N-methyl-d-aspartate in the rat hippocampus. Proceedings of the National Academy of Sciences USA 25 (1995) 3774-3778
79. Morrow A.L., Pace J.R., Purdy R.H., and Paul S.M. Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites. Molecular Pharmacology 37 (1990) 263-270
80. Morrow A.L., Suzdak P.D., and Paul S.M. Steroid hormone metabolites potentiate GABA receptor-mediated chloride ion flux with nanomolar potency. European Journal of Pharmacology 142 (1987) 483-485
81. Mtchedlishvili Z., Bertram E.H., and Kapur J. Diminished allopregnanolone enhancement of GABA(A) receptor currents in a rat model of chronic temporal lobe epilepsy. Journal of Physiology 1 (2001) 453-465
82. Noebels J.L. Isolating single genes of the inherited epilepsies. Annals of Neurology 16 (1984) 18-21
83. Noebels J.L. Mutational analysis of inherited epilepsies. Advances in Neurology 44 (1986) 97-113
84. Panayiotopoulos C. Absence epilepsies. In: Engel J., and Pedley T.A. (Eds). Epilepsy: A Comprehensive Textbook (1997), Lippincott-Raven Publishers, Philadelphia 2327-2346
85. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, London
86. Peeters B.W., Kerbush J.M., Coenen A.M., Vossen J.M., and van Luijtelaar E.L. Genetics of spike-wave discharges in the electroencephalogram (EEG) of the WAG/Rij inbred rat strain: a classical crossbreeding study. Behavior Genetics 22 (1992) 361-368
87. Peeters B.W., Ramakers G.M., Ellenbroek B.A., Vossen J.M., and Coenen A.M. Interactions between NMDA and nonNMDA receptors in nonconvulsive epilepsy in the WAG/Rij inbred strain. Brain Research Bulletin 33 (1994) 715-718
88. Peeters B.W., van Rijn C.M., Vossen J.M., and Coenen A.M. Effects of GABA-ergic agents on spontaneous non-convulsive epilepsy, EEG and behaviour, in the WAG/Rij inbred strain of rats. Life Sciences 45 (1989) 1171-1176
89. Peeters B.W., van Rijn C.M., Vossen J.M., and Coenen A.M. Involvement of NMDA receptors in non-convulsive epilepsy in WAG/Rij rats. Life Sciences 47 (1990) 523-529
90. A receptor by depressant barbiturates and pregnane steroid. British Journal of Pharmacology 94 (1988) 1257-1269
91. Pinault D. The thalamic reticular nucleus: structure, function and concept. Brain Research: Brain Research Reviews 46 (2004) 1-31
92. Ramakers G.M., Peeters B.W., Vossen J.M., and Coenen A.M. CNQX, a new non-NMDA receptor antagonist, reduces spike wave discharges in the WAG/Rij rat model of absence epilepsy. Epilepsy Research 9 (1991) 127-131
93. Reddy D.S. Pharmacology of endogenous neuroactive steroids. Critical Reviews in Neurobiology 15 (2003) 197-234
94. Reddy D.S., Kim H.Y., and Rogawski M.A. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 42 (2001) 328-336
95. Reddy D.S., and Kulkarni S.K. Development of neurosteroid-based novel psychotropic drugs. Progress in Medicinal Chemistry 37 (2000) 135-175
96. Reddy D.S., and Rogawski M.A. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia 42 (2001) 337-344
97. Richards D.A., Manning J.-P.A., Barnes D., Rombola L., Bowery N.G., Caccia S., Leresche N., and Crunelli V. Targeting thalamic nuclei is not sufficient for the full anti-absence action of ethosuximide in a rat model of absence epilepsy. Epilepsy Research 54 (2003) 97-107
98. Rogawski M.A. Progesterone, neurosteroids, and the hormonal basis of catamenial. epilepsy. Annals of Neurology 53 (2003) 288-291
99. Rupprecht R., and Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends in Neuroscience 22 (1999) 410-416
100. Russo E., Costanti A., Ferreri G., Citrato R., and De Sarro G. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy. Neuropharmacology 46 (2004) 865-878
101. Seidenbecher T., Staak R., and Pape H.C. Relations between cortical and thalamic cellular activities during absence seizures in rats. European Journal of Neuroscience 10 (1998) 1103-1112
102. Smith S.S. Withdrawal properties of a neuroactive steroid: implications for GABA(A) receptor gene regulation in the brain and anxiety behavior. Steroids 67 (2002) 519-528
103. Snead O.C. Basic mechanisms of generalized absence seizures. Annals of Neurology 37 (1995) 146-157
104. Snead O.C. Ganaxolone, a selective, high-affinity steroid modulator of the gamma-aminobutyric acid-A receptor, exacerbates seizures in animal models of absence. Annals of Neurology 44 (1998) 688-691
105. A receptor impairment in the genetic absence epilepsy rats from Strasbourg (GAERS): an immunocytochemical and receptor binding autoradiographic study. Epilepsy Research 15 (1993) 229-238
106. B receptors to thalamic neuronal activity during spontaneous absence seizures in rats. Journal of Neuroscience 21 (2001) 1378-1384
107. Steriade M. The GABAergic reticular nucleus: a preferential target of corticothalamic projections. Proceeding of the National Academy of Sciences USA 98 (2001) 3625-3627
108. Steriade M., and Contreras D. Spike-wave complexes and fast components of cortically generated seizures: I. Role of neocortex and thalamus. Journal of Neurophysiology 80 (1998) 1439-1455
109. Ueno S., Tsutsui M., Toyohira Y., Minami K., and Yanagihara N. Sites of positive allosteric modulation by neurosteroids on ionotropic gamma-aminobutyric acid receptor subunits. FEBS Letters 21 (2004) 213-217
110. Van Luijtelaar E.L., Ates N., and Coenen A.M. Role of L-type calcium channel modulation in non convulsive epilepsy in rats. Epilepsia 36 (1995) 86-92
111. Van Luijtelaar G., Budziszewska B., Jaworska-Feil L., Ellis J., Coenen A., and Lason W. The ovarian hormones and absence epilepsy: a long-term EEG study and pharmacological effects in a genetic absence epilepsy model. Epilepsy Research 46 (2001) 225-239
112. Van Luijtelaar G., Budziszewska B., Tetich M., and Lason W. Finasteride inhibits the progesterone-induced spike-wave discharges in a genetic model of absence epilepsy. Pharmacology, Biochemistry, and Behavior 75 (2003) 889-894
113. Vergnes M., and Marescaux C. Cortical and thalamic lesions in rats with genetic absence epilepsy. Journal of Neural Transmission 35 Suppl. (1992) 71-83
114. Wang C.G.T., and Snead III O.C. The GABAA receptor: subunit dependent functions and absence seizures. Epilepsy Currents 1 (2001) 1-5
115. Wisden W., Laurie D.J., Monyer H., and Seeburg P.H. The distribution of 13 GABA A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. Journal of Neuroscience 2 (1992) 1040-1062
116. Wu F.S., Gibbs T.T., and Farb D.H. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-d-aspartate receptor. Molecular Pharmacology 40 (1991) 333-336